Annals of Pediatric Gastroenterology and Hepatology ISPGHAN

Register      Login

VOLUME 3 , ISSUE 1 ( January-March, 2021 ) > List of Articles


Coronavirus Disease-19 Presenting as Acute Liver Failure in A Child

Sakshi Karkra, Yogesh Khurana, Rajiv Chhabra, Prabhat Maheshwari

Citation Information : Karkra S, Khurana Y, Chhabra R, Maheshwari P. Coronavirus Disease-19 Presenting as Acute Liver Failure in A Child. Ann Pediatr Gastroenterol Hepatol 2021; 3 (1):5-8.

DOI: 10.5005/jp-journals-11009-0069

License: CC BY-NC 4.0

Published Online: 06-07-2022

Copyright Statement:  Copyright © 2021; The Author(s).


PDF Share
  1. Wu J, Song S, Cao HC, Li LJ. Liver diseases in COVID-19: Etiology, treatment and prognosis. World J Gastroenterol. 2020;26(19):2286-2293. doi: 10.3748/wjg.v26.i19.2286
  2. Phipps MM, Barraza LH, LaSota ED, Sobieszczyk ME, Pereira MR, Zheng EX et al. Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large US Cohort. Hepatology 2020 maydoi: 10.1002/HEP.31404
  3. Zhang C, Shi L, Wang F. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020;5(5):428- 430.
  4. Chai X, Hu L, Zhang Y, Han W, Lu Z, Ke A et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. bioRxiv.2020.
  5. Jothimani D, Venugopal R, Abedin MF, Kaliamoorthy I, Rela M, Chairman F. COVID-19 and Liver. J Hepatol. 2020. doi: 10.1016/j.jhep.2020.06.006
  6. Garrido I, Liberal R, Macedo G. Review article: COVID-19 and liver disease-what we know on 1st May 2020. Aliment Pharmacol Ther. 2020;00:1-9.
  7. Ji D, Qin E, Xu J, Zhang D, Cheng G, Wang Y et al. Implication of nonalcoholic fatty liver diseases (NAFLD) in patients with COVID-19: a preliminary analysis. J Hepatol. 2020. https://doi. org/10.1016/j.jhep.2020.03.044
  8. Guan W-J, Ni Z-Y, Hu Y, Liang W-H, Ou C-Q, He J-X et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020 Feb 28
  9. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506.
  10. Wang L, He W, Yu X, Hu D, Bao M, Liu H et al. Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up. J Infect. 2020;80:639-645.
  11. Xu L, Liu J, Lu M, Yang D, Zheng X. Liver injury during highly pathogenic human coronavirus infections. Liver Int. 2020;40:998- 1004.
  12. Ludvigsson F. Systematic review of COVID-19 in children showsmilder cases and a better prognosis than adults. Acta Paediatr. 2020;109:1088-1095.
  13. Qiu H, Wu J, Hong L, Luo Y, Song Q, Chen D. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study. Lancet Infect Dis. 2020;20(6):689-696.
  14. Wang D, Ju L, Xie F, Lu Y, Li FY, Huang HH et al. Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces (autonomous region) of northern China. Zhonghua Er Ke Za Zhi. 2020;58(4):269-274.
  15. Zhu H, Wang L, Fang C, Peng S, Zhang L, Chang G et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr. 2020;9:51-60.
  16. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020 Feb 24
  17. American Association for the Study of Liver Diseases. Clinical insights for hepatology and liver transplant providers during the COVID-19 pandemic.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.